By Maureen Aylward An Ernst & Young report identifies two trends going on in biotech: an increase in research alliances between big pharma and start-up biotech firms and a rise in contingency-based payments for companies that reach milestones. We asked our Zintro experts for their thought leadership on these issues. Susanne Radke, PhD, an expert in [...]